Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “EPCAM”

Showing 3 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00352833
What this trial is testing

Safety and Efficacy Study With Catumaxomab in Patients After Curative Resection of a Gastric Adenocarcinoma

Who this might be right for
Gastric CancerGastric Adenocarcinoma
Neovii Biotech 40
Testing effectiveness (Phase 2)WithdrawnNCT04648189
What this trial is testing

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

Who this might be right for
Lung CancerSurgeryCirculating Tumor Cell
The Netherlands Cancer Institute
Not applicableUnknownNCT05703815
What this trial is testing

EpCAM and p53 Expressions in Infiltrating Duct Carcinoma of the Breast

Who this might be right for
Invasive Breast Cancer
Sohag University 40

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation